| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2022048684-A1 | Jnk inhibitor, pharmaceutical composition thereof and use thereof | 2020-09-07 |
| WO-2022039563-A1 | Novel compounds having inhibitory activity on prostaglandin e2 receptor and uses thereof | 2020-08-21 |
| WO-2022026892-A1 | Piperidin-1- yl-n-pyrydi ne-3-yl-2-oxoacet am ide derivatives useful for the treatment of mtap-deficient and/or mt a-accumulating cancers | 2020-07-31 |
| WO-2022015957-A1 | Compounds and compositions for treating conditions associated with sting activity | 2020-07-15 |
| WO-2021263278-A1 | Rev-erb agonists for the treatment of th17-mediated inflammatory disorders | 2020-06-23 |
| WO-2021226135-A1 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | 2020-05-04 |
| WO-2021133915-A1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 (enpp1) modulators and uses thereof | 2019-12-23 |
| TW-202128699-A | Therapeutic compounds | 2019-11-27 |
| WO-2021094763-A1 | Erap1 modulators | 2019-11-14 |
| WO-2021083380-A1 | Eed inhibitor, and preparation method therefor and use thereof | 2019-11-01 |
